TypeName: Business Offer
Country: United States
Summary: "BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex.
Potent helicase-primase inhibitor (HPI) effective against herpes simplex virus (HSV) infections with IC50 value of 20 nM for inhibition of the replication of both HSV-1 and HSV-2 in Vero cells, and ED50 value of 0.5 mg/kg for both HSV-1 and HSV-2 in the murine lethal challenge model of disseminated herpes."
https://www.bocsci.com/bay-57-1293-cas-348086-71-5-item-459053.html
Description: [RequestDescription]
OfferId: 2384
Name:Alex Brown
Telphone: